Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of IPO9 mRNA | CTD | PMID:27840820 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | IPO9 (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to IPO9 protein | CTD | PMID:32991956 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IPO9 mRNA | CTD | PMID:33387578 | 2,6-dinitrotoluene | affects expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of IPO9 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of IPO9 mRNA | CTD | PMID:30851411 | 3-chloropropane-1,2-diol | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of IPO9 protein | CTD | PMID:34915118 | 4,4'-sulfonyldiphenol | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of IPO9 protein | CTD | PMID:34186270 | acrylamide | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of IPO9 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | IPO9 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of IPO9 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of IPO9 mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of IPO9 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of IPO9 mRNA | CTD | PMID:24449571 | atrazine | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of IPO9 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of IPO9 mRNA | CTD | PMID:26238291 | benzo[a]pyrene | increases methylation | ISO | IPO9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of IPO9 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | IPO9 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of IPO9 3' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of IPO9 mRNA | CTD | PMID:26063408 | bisphenol A | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of IPO9 protein | CTD | PMID:37567409 | bisphenol A | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of IPO9 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of IPO9 protein | CTD | PMID:34186270 | bisphenol A | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of IPO9 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of IPO9 mRNA | CTD | PMID:30816183 more ... | buspirone | decreases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of IPO9 mRNA | CTD | PMID:24136188 | butanal | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of IPO9 mRNA | CTD | PMID:26079696 | calcitriol | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of IPO9 mRNA | CTD | PMID:16847355 | carbamazepine | affects expression | ISO | IPO9 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of IPO9 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of IPO9 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to IPO9 gene] | CTD | PMID:28238834 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IPO9 gene | CTD | PMID:20938992 | cobalt dichloride | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of IPO9 mRNA | CTD | PMID:19320972 and PMID:19376846 | copper atom | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Copper results in increased expression of IPO9 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Copper results in increased expression of IPO9 mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of IPO9 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of IPO9 mRNA | CTD | PMID:19167446 | coumestrol | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of IPO9 mRNA | CTD | PMID:19167446 | dicrotophos | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of IPO9 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPO9 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of IPO9 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | EXP | | 6480464 | Ethanol affects the expression of and affects the splicing of IPO9 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of IPO9 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IPO9 gene | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of IPO9 gene | CTD | PMID:31601247 | gentamycin | increases expression | ISO | Ipo9 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of IPO9 mRNA | CTD | PMID:22061828 and PMID:33387578 | ivermectin | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of IPO9 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IPO9 gene | CTD | PMID:20938992 | methidathion | decreases expression | EXP | | 6480464 | methidathion results in decreased expression of IPO9 mRNA | CTD | PMID:34813904 | methylmercury chloride | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of IPO9 mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of IPO9 mRNA | CTD | PMID:35430440 | paracetamol | increases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of IPO9 mRNA | CTD | PMID:22230336 | rac-lactic acid | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of IPO9 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of IPO9 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of IPO9 mRNA | CTD | PMID:19167446 and PMID:23557933 | rotenone | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of IPO9 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | tert-butyl hydroperoxide | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of IPO9 mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of IPO9 mRNA | CTD | PMID:31919559 | tetrahydropalmatine | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | tetrahydropalmatine results in decreased expression of IPO9 protein | CTD | PMID:20109541 | trichostatin A | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of IPO9 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | IPO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPO9 mRNA | CTD | PMID:27188386 | triptonide | affects expression | EXP | | 6480464 | triptonide affects the expression of IPO9 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of IPO9 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | IPO9 (Homo sapiens) | 6480464 | Urethane results in decreased expression of IPO9 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | IPO9 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of IPO9 mRNA | CTD | PMID:25979313 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype
Disease Annotations
Click to see Annotation Detail View
|
|
|
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
Gene Ontology Annotations
Click to see Annotation Detail View
Biological Process
|
|
Molecular Function
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
Mammalian Phenotype
|
|
|
References
References - curated
| # | Reference Title | Reference Citation |
| 1. | Functional annotation of a full-length mouse cDNA collection. | Kawai J, etal., Nature. 2001 Feb 8;409(6821):685-90. |
| 2. | Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development. | Ko MS, etal., Development 2000 Apr;127(8):1737-49. |
| 3. | MGDs mouse GO annotations | MGD data from the GO Consortium |
| 4. | Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. | Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73. |
| 5. | Mouse MP Annotation Import Pipeline | RGD automated import pipeline |
| 6. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
| 7. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
Additional References at PubMed
| PMID:8889548 | PMID:10349636 | PMID:10922068 | PMID:11042159 | PMID:11076861 | PMID:11493596 | PMID:11823430 | PMID:12447396 | PMID:12477932 | PMID:14610273 | PMID:15226823 | PMID:15368895 |
| PMID:15782199 | PMID:16141072 | PMID:16141073 | PMID:18799693 | PMID:19494118 | PMID:21267068 | PMID:21565611 | PMID:21677750 | PMID:21873635 | PMID:22323606 | PMID:22371338 | PMID:23605716 |
| PMID:24457600 | PMID:25737280 | PMID:26370502 | PMID:28378742 | PMID:29518331 | PMID:30333137 | PMID:32554809 |
Genomics
Comparative Map Data
| Ipo9 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPO9 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ipo9 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ipo9 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPO9 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPO9 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ipo9 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPO9 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPO9 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ipo9 (Heterocephalus glaber - naked mole-rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variants
.
Variants in Ipo9
1871 total Variants 
|
